Kristin Blouch

1.8k total citations
12 papers, 214 citations indexed

About

Kristin Blouch is a scholar working on Oncology, Immunology and Virology. According to data from OpenAlex, Kristin Blouch has authored 12 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 5 papers in Virology. Recurrent topics in Kristin Blouch's work include CAR-T cell therapy research (7 papers), HIV Research and Treatment (5 papers) and Immunotherapy and Immune Responses (3 papers). Kristin Blouch is often cited by papers focused on CAR-T cell therapy research (7 papers), HIV Research and Treatment (5 papers) and Immunotherapy and Immune Responses (3 papers). Kristin Blouch collaborates with scholars based in United States, France and Canada. Kristin Blouch's co-authors include Susan R. Ross, Spyridon Stavrou, Rahul M. Kohli, Edward P. Browne, Peter Tattersall, Yuki Nakaya, Wenming Zhao, Xueqing Maggie Lu, Taiga Nishihori and Marco Ruella and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kristin Blouch

11 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristin Blouch United States 5 124 111 79 46 44 12 214
Kirsten M. Knecht United States 8 113 0.9× 122 1.1× 85 1.1× 55 1.2× 45 1.0× 12 246
Thomas N. Denny United States 8 132 1.1× 76 0.7× 70 0.9× 43 0.9× 30 0.7× 11 226
Jiae Kim United States 8 110 0.9× 93 0.8× 126 1.6× 34 0.7× 60 1.4× 14 237
Hanne Vanderstraeten Belgium 6 108 0.9× 103 0.9× 147 1.9× 46 1.0× 76 1.7× 12 277
Giulia Della Chiara Italy 8 111 0.9× 190 1.7× 107 1.4× 37 0.8× 57 1.3× 11 328
Edurne García-Vidal Spain 10 127 1.0× 127 1.1× 85 1.1× 65 1.4× 74 1.7× 15 303
Néstor Vázquez Bernat Sweden 6 250 2.0× 120 1.1× 119 1.5× 39 0.8× 52 1.2× 8 338
Matthew Bell United Kingdom 7 94 0.8× 128 1.2× 24 0.3× 41 0.9× 43 1.0× 9 268
Juliane Kutzner Germany 6 55 0.4× 77 0.7× 59 0.7× 16 0.3× 37 0.8× 7 153
David S. Quinn United States 4 124 1.0× 133 1.2× 139 1.8× 54 1.2× 41 0.9× 8 268

Countries citing papers authored by Kristin Blouch

Since Specialization
Citations

This map shows the geographic impact of Kristin Blouch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristin Blouch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristin Blouch more than expected).

Fields of papers citing papers by Kristin Blouch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristin Blouch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristin Blouch. The network helps show where Kristin Blouch may publish in the future.

Co-authorship network of co-authors of Kristin Blouch

This figure shows the co-authorship network connecting the top 25 collaborators of Kristin Blouch. A scholar is included among the top collaborators of Kristin Blouch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristin Blouch. Kristin Blouch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Johnson, Melissa L., Adrian G. Sacher, Marcus O. Butler, et al.. (2021). 390 A global, molecular disease characterization initiative (MDCI) in oncology clinical trials. SHILAP Revista de lepidopterología. A423–A423. 1 indexed citations
4.
Klichinsky, Michael, Marco Ruella, Olga Shestova, et al.. (2020). Abstract PR07: Human chimeric antigen receptor (CAR) macrophages for cancer immunotherapy. Cancer Immunology Research. 8(4_Supplement). PR07–PR07. 2 indexed citations
5.
Rapoport, Aaron P., James E. Hoffman, Jonathan L. Kaufman, et al.. (2020). Open-label pilot study of genetically engineered NY-ESO-1–specific t cells (GSK3377794) alone or in combination with pembrolizumab in relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. 38(15_suppl). TPS8555–TPS8555. 3 indexed citations
6.
Nishihori, Taiga, Jonathan L. Kaufman, James E. Hoffman, et al.. (2020). Open-Label Pilot Study of Genetically Engineered NY-ESO-1 Specific T Cells (GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(3). S269–S270. 1 indexed citations
7.
Nishihori, Taiga, Jonathan L. Kaufman, James E. Hoffman, et al.. (2019). Open-Label Pilot Study of Genetically Engineered NY-ESO-1 Specific T Cells (GSK3377794) Alone or in Combination with Pembrolizumab in Relapsed and Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3134–3134. 2 indexed citations
8.
9.
Stavrou, Spyridon, Wenming Zhao, Kristin Blouch, & Susan R. Ross. (2018). Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. Journal of Virology. 92(11). 20 indexed citations
10.
Nakaya, Yuki, Spyridon Stavrou, Kristin Blouch, Peter Tattersall, & Susan R. Ross. (2016). In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models. Journal of Virology. 90(17). 8005–8012. 30 indexed citations
11.
Stavrou, Spyridon, et al.. (2015). Nucleic Acid Recognition Orchestrates the Anti-Viral Response to Retroviruses. Cell Host & Microbe. 17(4). 478–488. 56 indexed citations
12.
Stavrou, Spyridon, et al.. (2014). Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo. PLoS Pathogens. 10(5). e1004145–e1004145. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten M. Knecht Breakdown of academic impact, for papers by Thomas N. Denny Breakdown of academic impact, for papers by Jiae Kim Breakdown of academic impact, for papers by Hanne Vanderstraeten Breakdown of academic impact, for papers by Giulia Della Chiara Breakdown of academic impact, for papers by Edurne García-Vidal Breakdown of academic impact, for papers by Néstor Vázquez Bernat Breakdown of academic impact, for papers by Matthew Bell Breakdown of academic impact, for papers by Juliane Kutzner Breakdown of academic impact, for papers by David S. Quinn
Rankless by CCL
2026